Jak family of kinases in cancer

Amit K. Verma, Suman Kambhampati, Simrit Parmar, Leonidas C. Platanias

Research output: Contribution to journalArticle

102 Citations (Scopus)

Abstract

The family of Jak kinases is composed from at least four different tyrosine kinases (Tyk2, Jak1, Jak2, Jak3) that share significant structural homology with each other. The members of this family of kinases associate constitutively with a variety of cytokine and hormone receptors. Upon binding of the specific ligands to their receptors, Jak kinases are rapidly activated and their kinase activities induced, to regulate tyrosine phosphorylation of various effectors and initiate activation of downstream signaling pathways. The discovery of this family of tyrosine kinases dates back in the early 1990s with the cloning of the Tyk-2 tyrosine kinase as a critical element of the Type I interferon signaling pathway. Extensive work over the last few years has provided evidence that Jak kinases play important roles in the generation of responses for interferons, which are cytokines that exhibit important antitumor activities. There is also accumulating evidence that constitutive activation of different Jaks and Stats mediates neoplastic transformation and promotes abnormal cell proliferation in various malignancies. This review summarizes the role of various Jak-kinase dependent pathways in malignancies and discusses the therapeutic implications of the recent advances in the field.

Original languageEnglish (US)
Pages (from-to)423-434
Number of pages12
JournalCancer and Metastasis Reviews
Volume22
Issue number4
DOIs
StatePublished - Dec 2003
Externally publishedYes

Fingerprint

Phosphotransferases
Neoplasms
Protein-Tyrosine Kinases
TYK2 Kinase
Interferon Type I
Cytokine Receptors
Interferons
Tyrosine
Organism Cloning
Phosphorylation
Cell Proliferation
Hormones
Cytokines
Ligands
Therapeutics

Keywords

  • Cancer
  • Interferons
  • Janus kinases
  • Stat signaling

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Verma, A. K., Kambhampati, S., Parmar, S., & Platanias, L. C. (2003). Jak family of kinases in cancer. Cancer and Metastasis Reviews, 22(4), 423-434. https://doi.org/10.1023/A:1023805715476

Jak family of kinases in cancer. / Verma, Amit K.; Kambhampati, Suman; Parmar, Simrit; Platanias, Leonidas C.

In: Cancer and Metastasis Reviews, Vol. 22, No. 4, 12.2003, p. 423-434.

Research output: Contribution to journalArticle

Verma, AK, Kambhampati, S, Parmar, S & Platanias, LC 2003, 'Jak family of kinases in cancer', Cancer and Metastasis Reviews, vol. 22, no. 4, pp. 423-434. https://doi.org/10.1023/A:1023805715476
Verma, Amit K. ; Kambhampati, Suman ; Parmar, Simrit ; Platanias, Leonidas C. / Jak family of kinases in cancer. In: Cancer and Metastasis Reviews. 2003 ; Vol. 22, No. 4. pp. 423-434.
@article{8f6f6a172041498b837d985cd97f980d,
title = "Jak family of kinases in cancer",
abstract = "The family of Jak kinases is composed from at least four different tyrosine kinases (Tyk2, Jak1, Jak2, Jak3) that share significant structural homology with each other. The members of this family of kinases associate constitutively with a variety of cytokine and hormone receptors. Upon binding of the specific ligands to their receptors, Jak kinases are rapidly activated and their kinase activities induced, to regulate tyrosine phosphorylation of various effectors and initiate activation of downstream signaling pathways. The discovery of this family of tyrosine kinases dates back in the early 1990s with the cloning of the Tyk-2 tyrosine kinase as a critical element of the Type I interferon signaling pathway. Extensive work over the last few years has provided evidence that Jak kinases play important roles in the generation of responses for interferons, which are cytokines that exhibit important antitumor activities. There is also accumulating evidence that constitutive activation of different Jaks and Stats mediates neoplastic transformation and promotes abnormal cell proliferation in various malignancies. This review summarizes the role of various Jak-kinase dependent pathways in malignancies and discusses the therapeutic implications of the recent advances in the field.",
keywords = "Cancer, Interferons, Janus kinases, Stat signaling",
author = "Verma, {Amit K.} and Suman Kambhampati and Simrit Parmar and Platanias, {Leonidas C.}",
year = "2003",
month = "12",
doi = "10.1023/A:1023805715476",
language = "English (US)",
volume = "22",
pages = "423--434",
journal = "Cancer and Metastasis Reviews",
issn = "0167-7659",
publisher = "Springer Netherlands",
number = "4",

}

TY - JOUR

T1 - Jak family of kinases in cancer

AU - Verma, Amit K.

AU - Kambhampati, Suman

AU - Parmar, Simrit

AU - Platanias, Leonidas C.

PY - 2003/12

Y1 - 2003/12

N2 - The family of Jak kinases is composed from at least four different tyrosine kinases (Tyk2, Jak1, Jak2, Jak3) that share significant structural homology with each other. The members of this family of kinases associate constitutively with a variety of cytokine and hormone receptors. Upon binding of the specific ligands to their receptors, Jak kinases are rapidly activated and their kinase activities induced, to regulate tyrosine phosphorylation of various effectors and initiate activation of downstream signaling pathways. The discovery of this family of tyrosine kinases dates back in the early 1990s with the cloning of the Tyk-2 tyrosine kinase as a critical element of the Type I interferon signaling pathway. Extensive work over the last few years has provided evidence that Jak kinases play important roles in the generation of responses for interferons, which are cytokines that exhibit important antitumor activities. There is also accumulating evidence that constitutive activation of different Jaks and Stats mediates neoplastic transformation and promotes abnormal cell proliferation in various malignancies. This review summarizes the role of various Jak-kinase dependent pathways in malignancies and discusses the therapeutic implications of the recent advances in the field.

AB - The family of Jak kinases is composed from at least four different tyrosine kinases (Tyk2, Jak1, Jak2, Jak3) that share significant structural homology with each other. The members of this family of kinases associate constitutively with a variety of cytokine and hormone receptors. Upon binding of the specific ligands to their receptors, Jak kinases are rapidly activated and their kinase activities induced, to regulate tyrosine phosphorylation of various effectors and initiate activation of downstream signaling pathways. The discovery of this family of tyrosine kinases dates back in the early 1990s with the cloning of the Tyk-2 tyrosine kinase as a critical element of the Type I interferon signaling pathway. Extensive work over the last few years has provided evidence that Jak kinases play important roles in the generation of responses for interferons, which are cytokines that exhibit important antitumor activities. There is also accumulating evidence that constitutive activation of different Jaks and Stats mediates neoplastic transformation and promotes abnormal cell proliferation in various malignancies. This review summarizes the role of various Jak-kinase dependent pathways in malignancies and discusses the therapeutic implications of the recent advances in the field.

KW - Cancer

KW - Interferons

KW - Janus kinases

KW - Stat signaling

UR - http://www.scopus.com/inward/record.url?scp=0038386537&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038386537&partnerID=8YFLogxK

U2 - 10.1023/A:1023805715476

DO - 10.1023/A:1023805715476

M3 - Article

C2 - 12884916

AN - SCOPUS:0038386537

VL - 22

SP - 423

EP - 434

JO - Cancer and Metastasis Reviews

JF - Cancer and Metastasis Reviews

SN - 0167-7659

IS - 4

ER -